ABUS Operating Cash Flow (Statement)
Arbutus Biopharma Corp · Operating Cash Flow (Statement)
ABUS Operating Cash Flow (Statement)
Latest reported-$24.62Mperiod ending
ABUS TTM Cash from Operations (-$8.48M → -$24.62M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ABUS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -24,624,999 | |
| -34,355,999 | |
| -39,637,000 | |
| -45,272,000 | |
| -60,191,000 | |
| -58,946,000 | |
| -64,850,000 | |
| -71,827,000 | |
| -72,875,000 | |
| -77,930,000 | |
| -85,936,000 | |
| -85,634,000 | |
| -82,542,000 | |
| -83,276,000 | |
| -35,356,000 | |
| -37,972,000 | |
| -35,316,000 | |
| -29,032,000 | |
| -67,532,000 | |
| -62,939,000 | |
| -59,077,000 | |
| -53,869,000 | |
| -51,441,000 | |
| -49,779,000 | |
| -61,075,000 | |
| -69,879,000 | |
| -71,006,000 | |
| -74,730,000 | |
| -64,464,000 | |
| -64,481,000 | |
| -67,868,000 | |
| -61,135,000 | |
| -63,611,000 | |
| -51,067,000 | |
| -48,635,000 | |
| -53,115,000 | |
| -52,147,000 | |
| -63,873,000 | |
| -57,884,000 | |
| -59,679,000 | |
| -47,494,000 | |
| -47,361,000 | |
| -53,658,000 | |
| -43,887,000 | |
| -48,080,000 | |
| -39,419,000 | |
| -12,421,000 | |
| -3,021,963 | |
| 57,394 | |
| 5,287,464 | |
| -6,722,201 | |
| 31,444,625 | |
| 33,769,949 | |
| 34,794,547 | |
| 33,387,432 | |
| -7,468,410 | |
| -6,213,078 | |
| -8,635,165 | |
| -7,520,670 | |
| -11,166,496 | |
| -13,397,007 | |
| -9,140,152 | |
| -11,246,709 | |
| -9,228,870 | |
| -7,886,120 | |
| -9,605,818 | |
| -5,239,004 | |
| -5,152,472 | |
| -7,586,543 | |
| -8,751,517 | |
| -8,484,329 | |
| -5,773,570 | |
| -3,843,426 |